Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis.

Saeed Khorramnia Zia Navidi Amirhossein Orandi Mojgan Mohajeri Iravani Amirali Orandi Ebadallah Shiri Malekabad Seyed Hamid Pakzad Moghadam

Published in: Clinical transplantation and research (2024)

The evidence supporting the effectiveness of Tix/Cil as preexposure prophylaxis against SARS-CoV-2 in SOTRs is of a low to moderate level. Further high-quality research is necessary to understand its effects on this population.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
systematic review
men who have sex with men
high intensity